2h
News-Medical.Net on MSNGroundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth HoustonA stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.
Stem cells are cells that have the capacity to self-renew by dividing and to develop into more mature, specialised cells. Stem cells can be unipotent, multipotent, pluripotent or totipotent ...
9d
News Medical on MSNExploring the role of subventricular zone in neural regeneration, neurodegenerative diseasesThis recently published exploration into the subventricular zone (SVZ) highlights its critical role in neural regeneration, ...
The cornea is the clear, outermost layer of the eye. Its outer border, the limbus, contains a large volume of healthy stem ...
The company claims this hybrid system can learn and adapt faster than traditional silicon-based AI while consuming ...
4don MSN
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce ...
High-dose methotrexate (HD-MTX) with the modified Bonn protocol including intrathecal therapy is effective for patients less than 65 years old with primary central nervous system lymphoma (PCNSL), ...
A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...
If cells are removed from the embryo they will differentiate into any cell type. These are called embryonic stem cells. Some stem cells remain in the bodies of adults as adult stem cells.
How are induced pluripotent stem (iPS) cells different from embryonic stem (ES) cells? What can we use iPS cells for? ES cells were originally derived from the inner cell mass (ICM) or epiblast of ...
The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for more than two decades (since 2006), being the major obstacle for MSCs study and clinical application. The ...
Results from a phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 patients treated and tracked for 18 months had a more than 90% success rate at restoring the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results